| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |